Evidence map›Paper›PMID 40841459›Full record

ArticleBone marrow transplantation2025

Acute myeloid leukemia after CAR T-cell therapy: role of pre-existing clonal hematopoiesis and inflammation in leukemogenesis.

Paul Chauvet, Cynthia Saade, Julie Demaret, David Beauvais, Micha Srour, Leonardo Magro, Valérie Coiteux, Nicolas Gazeau, Nicolas Branche, Catherine Roche-Lestienne and 5 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Paul ChauvetCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France. chauvet.paul@outlook.fr.ORCID http://orcid.org/0000-0001-6326-9283
Cynthia SaadeCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.
Julie DemaretCHU de Lille, Institut d'Immunologie, Centre de Biologie Pathologie, Université de Lille, 59000, Lille, France.
David BeauvaisCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0003-1866-828X
Micha SrourCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0002-8519-4187
Leonardo MagroCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.
Valérie CoiteuxCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.
Nicolas GazeauCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.
Nicolas BrancheCHU de Nîmes, Hématologie Clinique, Nîmes, France.
Catherine Roche-LestienneInstitute of Medical Genetics, CHU Lille, Avenue Eugène Avinée, 59037 Lille Cedex and France Univ. Lille, Lille, France.
Laurène FenwarthLaboratory of Hematology, Lille University Hospital, Lille, France.
Elise FournierLaboratory of Hematology, Lille University Hospital, Lille, France.
Suman MitraCanther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.
Gandhi DamajCHU de Caen, Institut d'Hématologie, Université de Caen-Normandie, Caen, France.ORCID http://orcid.org/0000-0002-4689-3882
Ibrahim Yakoub-AghaCHU de Lille, Maladies du Sang, Université de Lille, 59000, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40841459

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.